Back to News
Market Impact: 0.15
TimeTeller puts our internal clocks at the center of personalized medicine
Source: TechCrunch
Healthcare & BiotechTechnology & InnovationProduct LaunchesPrivate Markets & Venture
German startup TimeTeller has developed a saliva test kit intended to help people understand their circadian rhythm. The company says the test aims to reduce side effects from cancer treatments; the article provides no efficacy data, regulatory status, or commercial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- Anthropic's third-quarter revenue is said to hit $16.8 billion ahead of IPO
- SK Hynix plunges 8% amid Asia tech rout as Fed rate hike fears, AI funding worries mount
- Why is Samsung Electronics stock plunging today?
- Why is Advantest stock plummeting today?
- Japan, U.S. reach first chip deal under $550 bln investment plan
- Elon Musk says Trump is 'ultimately' responsible for any curbs on Ukraine's Starshield systems
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Evaluate Consensus Estimates Platforms With AI
- Weekly Update: Adding Live MBO Level 3 Data - Liquidity Heatmap, OFI Charts, and More